Aviva’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.76M | Buy |
61,746
+56,420
| +1,059% | +$7.09M | 0.02% | 560 |
|
|
2025
Q1 | $589K | Sell |
5,326
-56,592
| -91% | -$6.26M | ﹤0.01% | 727 |
|
|
2024
Q4 | $8.45M | Buy |
61,918
+37,826
| +157% | +$5.16M | 0.02% | 472 |
|
|
2024
Q3 | $2.78M | Sell |
24,092
-39,459
| -62% | -$4.55M | 0.01% | 522 |
|
|
2024
Q2 | $8.75M | Sell |
63,551
-1,411
| -2% | -$194K | 0.02% | 451 |
|
|
2024
Q1 | $8.96M | Buy |
64,962
+5,994
| +10% | +$827K | 0.03% | 461 |
|
|
2023
Q4 | $7.77M | Buy |
58,968
+44,182
| +299% | +$5.82M | 0.03% | 472 |
|
|
2023
Q3 | $1.66M | Buy |
+14,786
| New | +$1.66M | 0.01% | 642 |
|
|
2022
Q4 | – | Sell |
-18,036
| Closed | -$1.92M | – | 1020 |
|
|
2022
Q3 | $1.92M | Sell |
18,036
-37,919
| -68% | -$4.03M | 0.01% | 712 |
|
|
2022
Q2 | $5.45M | Buy |
+55,955
| New | +$5.45M | 0.03% | 567 |
|
|
2022
Q1 | – | Sell |
-21,787
| Closed | -$1.86M | – | 1088 |
|
|
2021
Q4 | $1.86M | Buy |
+21,787
| New | +$1.86M | 0.01% | 872 |
|
|
2021
Q2 | – | Sell |
-13,950
| Closed | -$1.36M | – | 940 |
|
|
2021
Q1 | $1.36M | Buy |
13,950
+750
| +6% | +$73K | 0.01% | 740 |
|
|
2020
Q4 | $1.27M | Sell |
13,200
-9,622
| -42% | -$922K | 0.01% | 826 |
|
|
2020
Q3 | $2.2M | Buy |
22,822
+4,623
| +25% | +$445K | 0.01% | 753 |
|
|
2020
Q2 | $2.22M | Sell |
18,199
-22,144
| -55% | -$2.7M | 0.01% | 744 |
|
|
2020
Q1 | $3.49M | Buy |
40,343
+23,615
| +141% | +$2.04M | 0.03% | 609 |
|
|
2019
Q4 | $1.8M | Buy |
+16,728
| New | +$1.8M | 0.01% | 823 |
|
|
2014
Q3 | – | Sell |
-124,427
| Closed | -$1.85M | – | 845 |
|
|
2014
Q2 | $1.85M | Buy |
+124,427
| New | +$1.85M | 0.01% | 738 |
|
|
2014
Q1 | – | Sell |
-209,624
| Closed | -$1.96M | – | 819 |
|
|
2013
Q4 | $1.96M | Buy |
209,624
+3,226
| +2% | +$30.1K | 0.02% | 692 |
|
|
2013
Q3 | $2.34M | Buy |
206,398
+1,879
| +0.9% | +$21.3K | 0.02% | 650 |
|
|
2013
Q2 | $2.74M | Buy |
+204,519
| New | +$2.74M | 0.03% | 515 |
|